Bio-Reference Labs (BRLI) Tops Q2 EPS by 2c
More News related to BRLI
- Bio-Reference Laboratories, Inc. Again Awarded New York State Department of Corrections Laboratory Services Contract
- SmallCapSentinel.com: Records and Revenues
- BioReference Laboratories, Inc to Speak at the Oppenheimer 20th Annual Health Care Conference
- Bio-Reference Laboratories (BRLI) Tops The Q3 View By 8c
- Jefferies & Co Downgrades Bio-Reference Labs (BRLI) to Hold
More News related to Earnings
- Copart (CPRT) Reports Q1 EPS of $0.42, Beats by 1c
- PDL BioPharma (PDLI) Reports Q4 Revenues
- Shanda Games (GAME) Reports Q3 Adj-EPS of $0.24
- American Technology (ATCO) Posts Q3 Loss of 3c, Misses Views; Revs Higher Y/Y
- American Technology (ATCO) Reports '09 Financials
Bio-Reference Labs (Nasdaq: BRLI) reports Q2 earnings of $0.34 per share, above the consensus of $0.32. Revenues came in at $77.8 million, versus the consensus of $77.9 million.
Bio-Reference Laboratories, Inc. provides clinical laboratory testing services primarily in the greater New York metropolitan area.
Related Categories
EarningsStocks Mentioned
+0.94Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
